Gene · 9252
Papers1,701
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,701
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. | Pharmaceuticals (Basel) | 2022 | 36558921 | PubTator, text mining | PubMed |
| Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis. | J Neuroinflammation | 2022 | 36510261 | PubTator, text mining | PubMed |
| A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres. | Cancers (Basel) | 2022 | 36497426 | PubTator, text mining | PubMed |
| Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs. | Inorg Chem | 2022 | 36473464 | PubTator, text mining | PubMed |
| Mucosal circadian rhythm pathway genes altered by aging and periodontitis. | PLoS One | 2022 | 36472983 | PubTator, text mining | PubMed |
| Analysis of serum circulating MicroRNAs level in Malaysian patients with gestational diabetes mellitus. | Sci Rep | 2022 | 36434110 | PubTator, text mining | PubMed |
| Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development. | Molecules | 2022 | 36431829 | PubTator, text mining | PubMed |
| Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention. | Int J Mol Sci | 2022 | 36430404 | PubTator, text mining | PubMed |
| Mitochondrion-targeted RNA therapies as a potential treatment strategy for mitochondrial diseases. | Mol Ther Nucleic Acids | 2022 | 36420220 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. | Front Endocrinol (Lausanne) | 2022 | 36407322 | PubTator, text mining | PubMed |
| Cell-cell contact-driven EphB1 cis- and trans- signalings regulate cancer stem cells enrichment after chemotherapy. | Cell Death Dis | 2022 | 36402751 | PubTator, text mining | PubMed |
| PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36329884 | PubTator, text mining | PubMed |
| Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology. | Medicine (Baltimore) | 2022 | 36316840 | PubTator, text mining | PubMed |
| Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data. | BMC Cancer | 2022 | 36316649 | PubTator, text mining | PubMed |
| A Review of Omics Studies on Arboviruses: Alphavirus, Orthobunyavirus and Phlebovirus. | Viruses | 2022 | 36298749 | PubTator, text mining | PubMed |
| EGCG Prevents the Transcriptional Reprogramming of an Inflammatory and Immune-Suppressive Molecular Signature in Macrophage-like Differentiated Human HL60 Promyelocytic Leukemia Cells. | Cancers (Basel) | 2022 | 36291849 | PubTator, text mining | PubMed |
| Potential of Epidermal Growth Factor-like Peptide from the Sea Cucumber Stichopus horrens to Increase the Growth of Human Cells: In Silico Molecular Docking Approach. | Mar Drugs | 2022 | 36286420 | PubTator, text mining | PubMed |
| FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension. | Mediators Inflamm | 2022 | 36248192 | PubTator, text mining | PubMed |
| Recent updates on anticancer mechanisms of polyphenols. | Front Cell Dev Biol | 2022 | 36247004 | PubTator, text mining | PubMed |
| Identification and mechanism prediction of mulberroside A metabolites in vivo and in vitro of rats using an integrated strategy of UHPLC-Q-Exactive Plus Orbitrap MS and network pharmacology. | Front Chem | 2022 | 36238092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9252/papers?page=9